Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ludwig Institute For Cancer Research patents


Recent patent applications related to Ludwig Institute For Cancer Research. Ludwig Institute For Cancer Research is listed as an Agent/Assignee. Note: Ludwig Institute For Cancer Research may have other listings under different names/spellings. We're not affiliated with Ludwig Institute For Cancer Research, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Ludwig Institute For Cancer Research-related inventors


 new patent  Methods for modulating expression of c9orf72 antisense transcript

Disclosed herein are compositions and methods for reducing expression of c9orf72 antisense transcript in an animal with c9orf72 antisense transcript specific inhibitors. Such methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof. ... Ludwig Institute For Cancer Research

Plk4 inhibitors

Provided herein, inter alia, are compounds and methods for inhibiting plk4 and for treating cancer in a subject in need thereof.. . ... Ludwig Institute For Cancer Research

Methods of treating meningioma

The present invention relates to specific binding members, particularly antibodies and fragments thereof, which bind to amplified epidermal growth factor receptor (egfr) and to the de2-7 egfr truncation of the egfr. In particular, the epitope recognized by the specific binding members, particularly antibodies and fragments thereof, is enhanced or evident upon aberrant post-translational modification. ... Ludwig Institute For Cancer Research

Inkt cell modulators and methods of using the same

Disclosed herein are α-galactosylceramide (α-galcer) analogs and compositions thereof, methods of activating invariant natural killer t (inkt) cells using said analogs, methods of treating diseases by activating inkt cells using said analogs, and combination therapy of said analogs.. . ... Ludwig Institute For Cancer Research

Detection of epha3 as a marker of the presence of a solid tumor

The invention provides methods and compositions for detecting non-hematopoietic, non-tumor epha3-expressing cells in cancer patients and for monitoring the prognosis of patients using epha3.. . ... Ludwig Institute For Cancer Research

Devices and methods for prognosis prediction for melanoma cancer

The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. ... Ludwig Institute For Cancer Research

Liposomal formulation of nonglycosidic ceramides and uses thereof

The invention provides liposomes containing nonglycosidic ceramides within their bilayers, and compositions thereof. These liposomes activate murine inkt cells and induce dendritic cell (dc) maturation, both in vitro and in vivo at an efficacy that is comparable to their corresponding soluble nonglycosidic ceramides. ... Ludwig Institute For Cancer Research

Anti-metalloprotease antibody for diagnosis and treatment of cancers

Expression of proteolytically active, high molecular weight adam protease is relatively increased in tumour cells that also express the putative tumour stem cell marker cd133. An antibody or antibody fragment such as 8c7 monoclonal antibody may be used to selectively bind to proteolytically active, high molecular weight adam10 protease to thereby detect tumour cells and also as a therapeutic agent for treating cancers, tumours and other malignancies inclusive of leukemia, lymphoma, lung cancer, colon cancer, adenoma, neuroblastoma, brain tumour, renal tumour, prostate cancer, sarcoma and/or melanoma.. ... Ludwig Institute For Cancer Research








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ludwig Institute For Cancer Research in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ludwig Institute For Cancer Research with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###